NSE:SUNPHARMA (India)
Â
Ordinary Shares
₹
1485.75
(+0.07%)
Apr 24
Business Description
Sun Pharmaceuticals Industries Ltd
ISIN : INE044A01036
Share Class Description:
NSE:SUNPHARMA: Ordinary SharesCompare
Compare
Traded in other countries / regions
SUNPHARMA.India IPO Date
1995-02-08Description
Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.18 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.14 | |||||
| Interest Coverage | 39.38 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 14.9 | |||||
| Beneish M-Score | -2.06 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.2 | |||||
| 3-Year EBITDA Growth Rate | 18.1 | |||||
| 3-Year EPS without NRI Growth Rate | 30.3 | |||||
| 3-Year FCF Growth Rate | -16.9 | |||||
| 3-Year Book Growth Rate | 7.3 | |||||
| Future 3-5Y Total Revenue Growth Rate | 10.5 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.24 | |||||
| 9-Day RSI | 23.72 | |||||
| 14-Day RSI | 30.31 | |||||
| 6-1 Month Momentum % | 43.34 | |||||
| 12-1 Month Momentum % | 64.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.62 | |||||
| Quick Ratio | 1.96 | |||||
| Cash Ratio | 1.05 | |||||
| Days Inventory | 350.53 | |||||
| Days Sales Outstanding | 91.09 | |||||
| Days Payable | 190.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.84 | |||||
| Dividend Payout Ratio | 0.29 | |||||
| 3-Year Dividend Growth Rate | 22.2 | |||||
| Forward Dividend Yield % | 0.84 | |||||
| 5-Year Yield-on-Cost % | 3.58 | |||||
| Shareholder Yield % | 0.39 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 77.43 | |||||
| Operating Margin % | 21.74 | |||||
| Net Margin % | 19.08 | |||||
| FCF Margin % | 6.16 | |||||
| ROE % | 15.82 | |||||
| ROA % | 11.39 | |||||
| ROIC % | 15.25 | |||||
| ROC (Joel Greenblatt) % | 49.14 | |||||
| ROCE % | 17.65 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 39.57 | |||||
| PE Ratio without NRI | 37.56 | |||||
| Shiller PE Ratio | 53.97 | |||||
| Price-to-Owner-Earnings | 86.86 | |||||
| PEG Ratio | 3.16 | |||||
| PS Ratio | 7.55 | |||||
| PB Ratio | 5.89 | |||||
| Price-to-Tangible-Book | 8.48 | |||||
| Price-to-Free-Cash-Flow | 122.62 | |||||
| Price-to-Operating-Cash-Flow | 71.06 | |||||
| EV-to-EBIT | 31.81 | |||||
| EV-to-Forward-EBIT | 24.18 | |||||
| EV-to-EBITDA | 25.67 | |||||
| EV-to-Forward-EBITDA | 19.77 | |||||
| EV-to-Revenue | 7.34 | |||||
| EV-to-Forward-Revenue | 5.64 | |||||
| EV-to-FCF | 122.33 | |||||
| Price-to-Projected-FCF | 4.31 | |||||
| Price-to-DCF (Earnings Based) | 4.09 | |||||
| Price-to-DCF (FCF Based) | 13.36 | |||||
| Price-to-Median-PS-Value | 1.41 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.38 | |||||
| Price-to-Graham-Number | 3.87 | |||||
| Price-to-Net-Current-Asset-Value | 18.06 | |||||
| Earnings Yield (Greenblatt) % | 3.14 | |||||
| FCF Yield % | 0.81 | |||||
| Forward Rate of Return (Yacktman) % | 12.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sun Pharmaceuticals Industries Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 466,706.9 | ||
| EPS (TTM) (₹) | 37.1 | ||
| Beta | 0.69 | ||
| Volatility % | 21.86 | ||
| 14-Day RSI | 30.31 | ||
| 14-Day ATR (₹) | 30.596426 | ||
| 20-Day SMA (₹) | 1572.8 | ||
| 12-1 Month Momentum % | 64.32 | ||
| 52-Week Range (₹) | 922.45 - 1638.85 | ||
| Shares Outstanding (Mil) | 2,399.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sun Pharmaceuticals Industries Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sun Pharmaceuticals Industries Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sun Pharmaceuticals Industries Ltd Frequently Asked Questions
What is Sun Pharmaceuticals Industries Ltd(NSE:SUNPHARMA)'s stock price today?
The current price of NSE:SUNPHARMA is ₹1485.75. The 52 week high of NSE:SUNPHARMA is ₹1638.85 and 52 week low is ₹922.45.
When is next earnings date of Sun Pharmaceuticals Industries Ltd(NSE:SUNPHARMA)?
The next earnings date of Sun Pharmaceuticals Industries Ltd(NSE:SUNPHARMA) is 2024-05-24 Est..
Does Sun Pharmaceuticals Industries Ltd(NSE:SUNPHARMA) pay dividends? If so, how much?
The Dividend Yield %  of Sun Pharmaceuticals Industries Ltd(NSE:SUNPHARMA) is 0.84% (As of Today), Highest Dividend Payout Ratio of Sun Pharmaceuticals Industries Ltd(NSE:SUNPHARMA) was 0.35. The lowest was 0.04. And the median was 0.2. The  Forward Dividend Yield % of Sun Pharmaceuticals Industries Ltd(NSE:SUNPHARMA) is 0.84%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers